BI 2536 BS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 2536 BS, covering 2024-12-20 to 2024-12-20. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit [Phase 1]